1. Home
  2. Faculty

Anthony Fischer, MD, PhD

Clinical Assistant Professor of Pediatrics - Pulmonary Medicine

Current Positions

  • Interim Division Director, Division of Pediatric Pulmonary Medicine
  • Assistant Professor of Pediatrics - Pulmonary Medicine

Education

  • BS in Chemistry, Iowa State University, Ames, Iowa
  • MD/PhD in Medical Science Training Program, University of Iowa Carver College of Medicine, Iowa City, Iowa

Licenses & Certifications

  • Board Certified in Pediatric Pulmonology, ABP
  • Pediatric Advanced Life Support Certification
  • National Provider Identification, Federal DEA
  • Medical License, State of Iowa, Iowa
  • Controlled Substance Certification, State of Iowa, Iowa
  • Board Certified in General Pediatrics, ABP
  • Neonatal Resuscitation Program Certification
  • Medical License, Commonwealth of Pennsylvania

Selected Publications

  • Fischer, A. J., Singh, S. B., LaMarche, M. M., Maakestad, L. J., Kienenberger, Z. E., Pena, T. A., Stoltz, D. A. & Limoli, D. H. (2020). Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. DOI: 10.1164/rccm.202004-1322OC. PMID: 32750253.
  • Fischer, A. J., Kilgore, S. H., Singh, S. B., Allen, P. D., Hansen, A. R., Limoli, D. H. & Schlievert, P. M. (2019). High Prevalence of Staphylococcus aureus Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates. Genes 10 (12). DOI: 10.3390/genes10121036. PMID: 31842331.
  • Singh, S. B., McLearn-Montz, A. J., Milavetz, F., Gates, L. K., Fox, C., Murry, L. T., Sabus, A., Porterfield, H. S. & Fischer, A. J. (2019). Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor. Pediatric pulmonology 54 (8) 1200-1208. DOI: 10.1002/ppul.24341. PMID: 31012285. PMCID: PMC6641998.
  • Fischer, A. J., Pino-Argumedo, M. I., Hilkin, B. M., Shanrock, C. R., Gansemer, N. D., Chaly, A. L., Zarei, K., Allen, P. D., Ostedgaard, L. S., Hoffman, E. A., Stoltz, D. A., Welsh, M. J. & Alaiwa MHA (2019). Mucus strands from submucosal glands initiate mucociliary transport of large particles. JCI insight 4 (1). DOI: 10.1172/jci.insight.124863. PMID: 30626743.
  • Xie, Y., Ostedgaard, L., Abou Alaiwa, M., Lu, L., Fischer, A. J. & Stoltz, D. (In Press). Determinants of Mucociliary Transport in Healthy and CF Airways. Annals of the American Thoracic Society. PMID: 30431346.
  • Akil, N. & Fischer, A. J. (2018). Surfactant deficiency syndrome in an infant with a C-terminal frame shift in ABCA3: A case report. Pediatr Pulmonol 53 (5) 12-14. PMID: 29566461.
  • Fischer, A. J. & LeGrys, V. (2017). Sweat Test Clinical Care Guidelines. Cystic Fibrosis Foundation.
  • Strang, A., Fischer, A. J. & Chidekel, A. (2017). Pseudomonas eradication and clinical effectivness of Ivacaftor in four Hispanic patients with S549N. Pediatric pulmonology. DOI: 10.1002/ppul.23665. PMID: 28371569.
  • Liming, B., Fischer, A. & Pitcher, G. (2017). Bronchial Compression and Tracheosophageal Fistula Secondary to Prolonged Esophageal Foreign Body. Ann Otol Rhinol Laryngol 125 (12) 1030-1033.
  • Adam, R. J., Hisert, K. B., Dodd, J. D., Grogan, B., Launspach, J. L., Barnes, J. K., Gallagher, C. G., Sieren, J. P., Gross, T. J., Fischer, A. J., Cavanaugh, J. E., Hoffman, E. A., Singh, P. K., Welsh, M. J., McKone, E. F. & Stoltz, D. A. (2016). Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities. JCI insight 1 (4) e86183. DOI: 10.1172/jci.insight.86183. PMID: 27158673.